Company news

Celcuity Inc. news in 2022

Celcuity Inc.'s news releases, calls and decks from 2022, newest first.

View company

Celcuity Closes $100 Million Private Placement

December 11, 2022

Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib in Patients with Advanced Breast Cancer at the 2022 San Antonio Breast Cancer Symposium

December 8, 2022

Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib for the Treatment of HR+/HER2- Advanced Breast Cancer

December 6, 2022

Celcuity to Present Additional Data for Gedatolisib at the 2022 San Antonio Breast Cancer Symposium

November 21, 2022

Celcuity to Participate in the 13th Annual Craig-Hallum Alpha Select Conference

November 9, 2022

Celcuity Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 9, 2022

Celcuity Inc. Schedules Release of Third Quarter 2022 Financial Results and Webcast/Conference Call

November 2, 2022

Celcuity Appoints Polly Murphy, D.V.M., Ph.D., to Board of Directors

September 13, 2022

Celcuity Inc. Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 10, 2022

Celcuity Inc. Schedules Release of Second Quarter 2022 Financial Results and Webcast/Conference Call

August 3, 2022

Celcuity to Participate in the Canaccord Genuity 42nd Annual Growth Conference

August 2, 2022

Celcuity Announces FDA Breakthrough Therapy Designation for Gedatolisib for Treatment of HR+/HER2- Metastatic Breast Cancer

July 17, 2022

Celcuity Inc. Reports First Quarter 2022 Financial Results and Business Updates

May 15, 2022

Celcuity Inc. Announces $100 Million Private Placement

May 15, 2022

Celcuity Inc. Schedules Release of First Quarter 2022 Financial Results and Webcast/Conference Call

May 8, 2022

Celcuity to Participate in Upcoming Needham and Canaccord Genuity Investor Conferences

April 4, 2022

Celcuity Inc. Reports Fourth Quarter and Full Year 2021 Financial Results, Pivotal Phase 3 Trial Design for Gedatolisib in the Treatment of Advanced Breast Cancer, and Business Updates

March 22, 2022

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2021 Financial Results and Webcast/Conference Call

March 15, 2022

Celcuity to Participate in the Cowen 42nd Annual Health Care Conference

March 1, 2022

Celcuity Receives FDA Fast Track Designation for Gedatolisib in HR+ / HER2- Metastatic Breast Cancer and Provides Corporate Update

January 17, 2022

Calls in 2022

Decks in 2022